Publications by authors named "Maria Pietanza"

12Publications

No Decision Is Final: Career Planning and Career Transitions.

Am Soc Clin Oncol Educ Book 2018 May;38:881-886

From the Louisiana State University Health Sciences Center, New Orleans, LA; U.S. Food and Drug Administration, Silver Spring, MD, The Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD; Memorial Cancer Institute, Hollywood, FL; Merck & Co., Inc., Rahway, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_200983DOI Listing
May 2018

Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy.

Nat Commun 2017 07 17;8:16078. Epub 2017 Jul 17.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms16078DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520052PMC
July 2017

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer.

J Clin Oncol 2016 11;34(31):3740-3748

Martin Reck, LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf; Michael Thomas, Translational Lung Research Center Heidelberg, Thoraxklinik im Universitätsklinikum Heidelberg, Heidelberg, Germany; Alexander Luft, Leningrad Regional Clinical Hospital, Leningrad, Russia; Aleksandra Szczesna, Mazowieckie Centrum Leczenia Chorob Pluc i Gruzlicy w Otwocku, Otwocku, Poland; Libor Havel, Hospital Na Bulovce, Prague, Czech Republic; Sang-We Kim, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea; Wallace Akerley, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Maria Catherine Pietanza, Memorial Sloan Kettering Cancer Center, New York, NY; Kathryn Gold, University of Texas MD Anderson Cancer Center, Houston, TX; Leora Horn, Vanderbilt-Ingram Cancer Center; David Spigel, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Anne Pieters, Teresa Kong Sanchez, and Justin Fairchild, Bristol-Myers Squibb, Princeton, NJ; Yi-long Wu, Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong, People's Republic of China; Christoph Zielinski, Medical University of Vienna, Vienna, Austria; Enriqueta Felip, Vall d'Hebron University Hospital, Barcelona, Spain; Joachim Aerts, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Kazuhiko Nakagawa, Kinki University Hospital, Osaka, Japan; and Paul Lorigan, the Christie NHS Foundation Trust, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.67.6601
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.67.6601DOI Listing
November 2016

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.

Clin Lung Cancer 2016 09 21;17(5):e121-e129. Epub 2016 Jan 21.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474315PMC
September 2016

Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience.

Ann Thorac Surg 2011 Oct 25;92(4):1180-6; discussion 1186-7. Epub 2011 Aug 25.

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2011.05.027DOI Listing
October 2011

A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed.

J Thorac Oncol 2011 Mar;6(3):624-6

Division of Solid Tumor Oncology, Thoracic Oncology Services, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641532221
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e318207f788DOI Listing
March 2011

Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.

J Thorac Oncol 2010 Oct;5(10):1623-9

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181ec1531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020424PMC
October 2010